Up to now, ULK1 as a potential target for autophagy activity regulation has been reported in a large amount of the literature, and ULK1 inhibitors have been reported to function in lung cancer cells, FLT3‐ITD‐mutated acute myeloid leukemia and neuroblastoma [8, 19, 20, 22]. This evidence concerns the gene FLT3 and neuroblastoma.